Transcatheter aortic valve replacement using the SAPIEN 3 valve versus surgical aortic valve replacement using the rapid deployment INTUITY valve: Midterm outcomes
Autor: | Elias Ewais, Justus Strauch, Polykarpos C. Patsalis, Matthias Bechtel, Dritan Useini, Peter L. Haldenwang, Markus Schlömicher, Blerta Beluli, V. Moustafine, Hildegard Christ |
---|---|
Rok vydání: | 2021 |
Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty Transcatheter aortic medicine.medical_treatment Hemodynamics 030204 cardiovascular system & hematology Transcatheter Aortic Valve Replacement 03 medical and health sciences 0302 clinical medicine Valve replacement Aortic valve replacement Risk Factors medicine Humans Endocarditis Stroke Heart Valve Prosthesis Implantation business.industry Aortic Valve Stenosis medicine.disease Surgery Stenosis Treatment Outcome 030228 respiratory system Aortic Valve Heart Valve Prosthesis Permanent pacemaker Cardiology and Cardiovascular Medicine business |
Zdroj: | Journal of Cardiac Surgery. 36:610-617 |
ISSN: | 1540-8191 0886-0440 |
DOI: | 10.1111/jocs.15275 |
Popis: | OBJECTIVES Little data have been published on the midterm effect of transapical/transfemoral-transcatheter aortic valve replacement (TA-/TF-TAVR) using the Edwards SAPIEN 3 valve (S3). We aimed to compare the outcomes after TA-/TF-TAVR utilizing the S3 (TA-/TF-S3) valve with those after surgical aortic valve replacement utilizing the rapid deployment Edwards INTUITY valve (RD-SAVR). METHODS Between March 2012 and April 2018, 122 patients with aortic stenosis underwent TA-S3, 77 patients underwent TF-S3 and 182 patients underwent RD-SAVR through partial sternotomy at our institution. We conducted clinical and echocardiographic midterm follow-ups. The primary outcomes of the study were the incidence of new pacemakers permanent pacemaker implantation (PPI), the occurrence of paravalvular leakage (PVL) and the hemodynamic performance of the valves. RESULTS All study groups were at intermediate surgical risk. The 30-day all-cause mortality and stroke rates in the TA-S3, TF-S3, and RD-SAVR groups were 4.1% and 1.6%, 3.9% and 2.6%, and 3.8% and 2.2%, respectively. The RD-SAVR group had significantly smaller PVL and PPI rates than did the TA-/TF-S3 group (p |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |